| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/21/2006 | WO2006060723A9 Methods for producing block copolymer/amphiphilic particles |
| 09/21/2006 | WO2006055878A3 Exfoliating skin care product |
| 09/21/2006 | WO2006048261A3 Oral solid dosage forms containing a low dose of estradiol |
| 09/21/2006 | WO2006038080A3 Contact lens package solution |
| 09/21/2006 | WO2006037061A3 Compositions and methods of using d-dopa to treat parkinson's disease |
| 09/21/2006 | WO2006010605A3 Sustained release pharmaceutical particulate composition comprising venlafaxine |
| 09/21/2006 | WO2006007372A3 Drug delivery product and methods |
| 09/21/2006 | WO2005120456A3 Formulation of eletriptan |
| 09/21/2006 | WO2005112897A3 Immediate release pharmaceutical tablets with height greater than width |
| 09/21/2006 | WO2005007137A8 Tablets containing ambroxol |
| 09/21/2006 | US20060212950 Inducible small rna expression constructs for targeted gene silencing |
| 09/21/2006 | US20060211982 Intracutaneous injection |
| 09/21/2006 | US20060211860 Compounds for the treatment of Alzheimer's disease |
| 09/21/2006 | US20060211688 Vehicle for topical delivery of anti-inflammatory compounds |
| 09/21/2006 | US20060211664 Method for treating erectile dysfunction and increasing libido in men |
| 09/21/2006 | US20060211663 Low dose estrogen interrupted hormone replacement therapy |
| 09/21/2006 | US20060211654 Pharmaceutical Compositions of Cholesteryl Ester Transfer Protein Inhibitor |
| 09/21/2006 | US20060211642 Controlling gene expression; enzyme inhibitors |
| 09/21/2006 | US20060211637 Methods of down regulating target gene expression in vivo by introduction of interfering rna |
| 09/21/2006 | US20060211608 Use of a parathyroid hormone peptide analogs for the treatment of viginal atrophy |
| 09/21/2006 | US20060211599 Reversibly heat-gelable aqueous composition |
| 09/21/2006 | US20060210747 Compositions and medical devices utilizing bioabsorbable polymeric waxes |
| 09/21/2006 | US20060210710 Processes for manufacturing polymeric microspheres |
| 09/21/2006 | US20060210641 Absorbable microparticles |
| 09/21/2006 | US20060210640 Process for producing nanoparticles by spray drying |
| 09/21/2006 | US20060210639 Nanoparticulate bisphosphonate compositions |
| 09/21/2006 | US20060210638 Injectable compositions of nanoparticulate immunosuppressive compounds |
| 09/21/2006 | US20060210637 Stable tablet dosage forms of proton pump inhibitors |
| 09/21/2006 | US20060210636 Nanoscale core/shell particles and the production thereof |
| 09/21/2006 | US20060210635 Injectable gel-forming compositions based on cross-linked and non-cross-linked polymers and the use thereof |
| 09/21/2006 | US20060210634 Ceramic structures for controlled release of biologically active substances |
| 09/21/2006 | US20060210633 Programmed drug delivery system |
| 09/21/2006 | US20060210632 Sublingual coated tablet of fentanyl |
| 09/21/2006 | US20060210631 Multi-particulate, modified-release composition |
| 09/21/2006 | US20060210630 Controlled release compositions of gamma-hydroxybutyrate |
| 09/21/2006 | US20060210629 Zinc-containing sustained-release composition, its preparation, and method for producing the same |
| 09/21/2006 | US20060210628 Use of epinine for enhancing physical performance |
| 09/21/2006 | US20060210627 Direct compression formulation and process |
| 09/21/2006 | US20060210626 Radio frequency identification pharmaceutical tracking system and method |
| 09/21/2006 | US20060210625 Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms |
| 09/21/2006 | US20060210624 Combination product comprising an antagonist or inverse agonist of histamine receptor h<sb>3 </sb>and an antipsychotic and antidepressant agent, and use thereof for the preparation of a medicament that prevents the adverse effects of psychotropic drugs |
| 09/21/2006 | US20060210623 Sustained release delivery of isradipine |
| 09/21/2006 | US20060210622 Surface modified particulate compositions of biologically active substances |
| 09/21/2006 | US20060210621 consisting of partially hydrolyzed fucoidan, plum concentrate, grape concentrate, black currant concentrate, blueberry concentrate, raspberry concentrate, black pepper extract, Sichuan pepper extract, minerals, flavoring agent, and sweetener |
| 09/21/2006 | US20060210620 Co-precipitated amorphous losartan and dosage forms comprising the same |
| 09/21/2006 | US20060210619 Limposomes containing asiaticoside and the uses thereof |
| 09/21/2006 | US20060210618 Polyglycrine based phospholipid containing amide groups; surfactant, solubilizer, dispersant for cosmetics, lipid membrane for drug delivery systems |
| 09/21/2006 | US20060210617 Selected solvent is one that can substantially or fully solvate or dissolve the adhesive while keeping the fentanyl suspended in the solvated adhesive; provides non-invasive sustained analgesia for periods ranging from 24 hours to 168 hours |
| 09/21/2006 | US20060210616 Therapeutic patch for ophthalmologic and cosmetic use |
| 09/21/2006 | US20060210615 Dermal or transdermal therapeutic system comprising an ormocer with barrier effect on a cover foil |
| 09/21/2006 | US20060210614 Method of treatment of a metabolic disease using intranasal administration of exendin peptide |
| 09/21/2006 | US20060210612 Make-up-removing article |
| 09/21/2006 | US20060210599 Injectable or sprayable nonpolymeric ester or mixed ester solution easily formulated with therapeutic agents |
| 09/21/2006 | US20060210598 Resorbable structure for treating and healing of tissue defects |
| 09/21/2006 | US20060210593 Methods of making and methods of using antiseptic disinfectant, cosmetic and toiletries, medicine or food containing the same |
| 09/21/2006 | US20060210592 Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis |
| 09/21/2006 | US20060210552 Compositions and methods for systemic inhibition of cartilage degradation |
| 09/21/2006 | US20060210550 Angiogenesis inducer |
| 09/21/2006 | US20060210549 Controlled release liposomes and methods of use |
| 09/21/2006 | US20060210528 Therapy for tropical diseases |
| 09/21/2006 | US20060210490 Confection for teeth whitening and oral hygiene |
| 09/21/2006 | US20060210489 Antibacterial 3',5-disubstituted 2,4'-dihydroxybiphenyl compounds, derivatives and related methods |
| 09/21/2006 | US20060210488 Teeth whitening candy with tartar removal and breath freshening properties |
| 09/21/2006 | US20060210487 Hair wax products containing waxes, non-volatile oils and volatile hydrophobic materials |
| 09/21/2006 | US20060210486 Aerosol antiperspirant with polyamide |
| 09/21/2006 | US20060210485 Pharmaceutical formulations |
| 09/21/2006 | US20060210484 Transmucosal absorption through oral mucosa to systemic circulatory system; bioavailability, rapid onset; active ingredient, solvent and low molecular weight hydrocarbon propellant |
| 09/21/2006 | US20060207495 Temperature activated systems |
| 09/21/2006 | DE4404086B4 Pharmazeutische und/oder kosmetische Zusammensetzung Pharmaceutical and / or cosmetic composition |
| 09/21/2006 | DE102005042875A1 Schnell freisetzende Darreichungsformen für Antibiotika Quick-release dosage forms of antibiotics |
| 09/21/2006 | DE102005011785A1 Langzeitstabile kosmetische Emulsionen Long-term stable cosmetic emulsions |
| 09/21/2006 | DE102005011691A1 Cosmetic and/or pharmaceutical composition, useful for cleaning and protecting the human skin and hair, comprises hydrocarbon, which is obtained by kolbe electrolysis of fatty acids |
| 09/21/2006 | CA2602089A1 Tigecycline compositions and methods of preparation |
| 09/21/2006 | CA2602074A1 An aqueous polymeric system for pressure sensitive adhesive matrix preparation |
| 09/21/2006 | CA2602031A1 Nanoparticles of chitosan and polyethyleneglycol as a system for the administration of biologically-active molecules |
| 09/21/2006 | CA2601250A1 Taste masked dosage form containing roflumilast |
| 09/21/2006 | CA2601179A1 Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations |
| 09/21/2006 | CA2601123A1 External preparation |
| 09/21/2006 | CA2600736A1 Delivery system for multiple drugs |
| 09/21/2006 | CA2600542A1 Pharmaceutical tablets of crystalline type ii aripiprazole |
| 09/21/2006 | CA2600462A1 Compositions comprising entrained water and agents entrained in water-sensitive matrices |
| 09/21/2006 | CA2600446A1 Novel liposome compositions |
| 09/21/2006 | CA2599653A1 Methods of reducing microbial contamination |
| 09/21/2006 | CA2599502A1 Sublingual coated tablet |
| 09/21/2006 | CA2598985A1 Antimicrobial pet wipes and methods |
| 09/21/2006 | CA2578524A1 A suspension comprising an active principle, a suspending vehicle, a density-modifying solid with an increased physical stability |
| 09/21/2006 | CA2563533A1 Compositions capable of facilitating penetration across a biological barrier |
| 09/21/2006 | CA2501681A1 Paper medication |
| 09/21/2006 | CA2500750A1 Liquid compound added to the preparation of cigarette, cigar and pipe tobacco and chewing tobacco. designed to reduce the risk of disease caused by tobacco smoke. |
| 09/20/2006 | EP1703014A1 Allergen suppressor, allergen-suppression processed fiber and method of producing the same |
| 09/20/2006 | EP1702983A2 Tissue-specific and pathogen-specific toxic agents, ribozymes, DNAzymes and antisense oligonucleotides and methods of use thereof |
| 09/20/2006 | EP1702914A1 Radio-opaque polymeric biomaterials |
| 09/20/2006 | EP1702886A1 Porous silica having substance carried thereon |
| 09/20/2006 | EP1702635A2 Transcutaneous delivery means |
| 09/20/2006 | EP1702619A2 Disinfecting and solubilizing steroid compositions |
| 09/20/2006 | EP1702612A1 Butylphtalide soft gel capsulte and its preparation procedure |
| 09/20/2006 | EP1702597A2 Drug delivery of phase changing formulation |
| 09/20/2006 | EP1702161A2 Oxidative reductive potential water solution, processes for producing same and methods of using the same |
| 09/20/2006 | EP1702056A2 Non-animal product containing veterinary formulations |
| 09/20/2006 | EP1701981A1 Cohesive gels from cross-linked hyaluronan and/or hylan,their preparation and use |